微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.16% | -93.42% | -91.92% | 107/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 1.98% | -41.42% | -37.74% | 90/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 3.18% | -42.39% | 20% | 83/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.65% | -41.11% | 9.05% | 69/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.43% | -26.81% | -28.11% | 51/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 3.38% | -72% | -38.77% | 76/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.52% | -39.34% | 22.67% | 63/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.5% | -26.35% | 35.54% | 48/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.32% | -1.78% | -72.49% | 30/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 12.07% | 2.03% | 32.64% | 30/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.1% | 7.95% | 48.94% | 36/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.11% | 8.72% | 80.77% | 36/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.38% | 1.5% | -71.43% | 29/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 11.83% | 2.34% | 40.33% | 36/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.43% | -27.08% | 50% | 49/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.62% | -10.79% | 68.77% | 48/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.33% | 0% | -71.19% | 37/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 11.56% | 15.95% | 0% | 45/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 11.56% | 6.84% | 83.49% | 29/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 6.3% | 9.95% | 89.19% | 42/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.33% | 1.83% | -66.6% | 28/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 9.97% | -2.92% | -7.86% | 58/159 | 2.71% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.82% | 8.85% | 88.83% | 29/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.73% | 4.75% | 75.23% | 41/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.27% | 19.34% | -68.16% | 34/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 10.27% | -45.08% | 3.32% | 49/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.94% | 2% | 81.72% | 25/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.47% | -45.14% | 99.64% | 34/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.74% | 2% | -85.35% | 36/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 18.7% | -11.08% | 87.56% | 16/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 9.97% | -23.19% | -52.59% | 16/159 | 5.59% | 一品红 | 31.62% | 行业排名> |
| 2016-12-31 | 21.03% | -12.38% | -12.38% | 23/159 | 6.33% | 丽珠集团 | 49.43% | 行业排名> |
| 2015-12-31 | 24% | 9.49% | 84.9% | 17/159 | 11.35% | 河化股份 | 54.24% | 行业排名> |
| 2015-06-30 | 12.98% | 2% | -40.78% | 9/159 | 4.9% | 华东医药 | 7.2% | 行业排名> |